Pharma giant Merck just lowered the prices of some of its medications (MRK)
AP
- Merck said Thursday that it would lower the price of some of its medications including its hepatitis C drug Zepatier by 60%.
- The decision comes a little over a week after President Donald J. Trump singled out rival Pfizer over its price increases. The move prompted Pfizer to defer its increases until the end of the year and Novartis to commit to not increasing prices for the rest of the year.
- Merck also said it won't increase the net price of its medications by more than the rate of inflation.
Amid scrutiny over big pharma drug pricing, Merck said on Thursday it would lower the price of some of its medications.
The pharmaceutical giant said it would reduce the cost of its hepatitis C medication Zepatier by 60%. See the rest of the story at Business Insider
See Also:
- 'It's akin to us cancelling scheduled ice fishing trips during July and August:' Trump is claiming a win after drugmakers committed not to increase prices for the rest of the year but it could have little impact on patients
- Nobody wants to buy the world's largest log cabin
- Qatar Airways CEO says business has gotten better, not worse, with Trump in office